Home
Beta Drugs Ltd Share Price History

Beta Drugs Ltd
NSE : 21 Feb, 2025
1649.3-79.1 (-4.6%)
Prev Close
1728.3
Open Price
1741.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
2000
Today's High / Low
1745.1 / 1625.0
52 WK High / Low
2326.0 / 1060.1
Market Price of Beta Drugs Ltd
1M
1Y
3Y
5Y
Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
Date | Price | Open | High | Low |
---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
Parameter | |
---|---|
Sales (Cr.) | NaN |
Sales YoY Gr. | - |
Adj EPS | 7.82 |
YoY Gr. | - |
Net Profit (Cr.) | 7 |
BVPS | 38.02 |
Key Financial Parameters
Parameter | |
---|---|
Return on Capital Emp. % | 19.22 |
Op. Profit Mgn % | 19.18 |
Net Profit Mgn % | 13.37 |
Debt to Equity % | 0.23 |
Latest Shareholding
Promoters Holdings Over Time
About Beta Drugs Ltd
- Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
- Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
- Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
- The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
- The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.
Popular Search
FAQs for Beta Drugs Ltd Share Price History
What are the key events that typically impact Beta Drugs Ltd's share price history?
Key events that impact Beta Drugs Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Beta Drugs Ltd's share price history?
Stock splits reduce the nominal price of Beta Drugs Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Beta Drugs Ltd?
Dividends can influence Beta Drugs Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Beta Drugs Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Beta Drugs Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Beta Drugs Ltd’s share price history?
To understand Beta Drugs Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.